Following an initial dose response study, metoprolol, a selective PI-receptor blocking agent, was compared with equipotent dosages of propranolol in a double blind cross-over study, including exercise tolerance tests, on fourteen patients with angina pectoris. Long term therapy with metoprolol then followed until the seventy-second week.
DURING the last 2 years, there has been increasing clinical interest in the response of angina patients to a new generation of adrenergic P-receptor blocking agents shown to have selectivity towards 31-receptors. It had been suggested that such compounds might produce therapeutically desirable cardiac f-blockade without the adverse effects associated with constriction of vascular and bronchial smooth muscle resulting from interference with the P,-receptors.
Practolol was the first to be used extensively in clinical practice, but in view of the increasing adverse reports of oculomucocutaneous syndrome (Felix, Ive and Dahl, 1974; Wright, 1975) , and sclerosing peritonitis (Windsor, Kurrein and Dyer, 1975) , practolol should now be considered unsuitable as a therapeutic agent in the long term treatment of angina.
Metoprolol (1-(4-(2-methoxyethyl)phenoxy)-3-isopropylamino-propanol) has been described, in animal studies, as a selective antagonist in that it blocked the effects of isoprenaline on the adrenergic P-receptors in the heart in much lower doses than were required to block the effects of isoprenaline on the P-receptors in vascular and bronchial smooth muscle (Ablad, Carlsson and Ek, 1973) . Clinicopharmacologically, it has been shown to be equally selective as practolol when the response to isoprenaline was measured in patients with chronic obstructive lung disease (Thiringer and Svedmyr, 1976) . Although the plasma half-life in man is of the order of 3-4 hr. the time for 50% reduction of the maximum pharmacological effect of 100 mg orally on the reduction of exercise tachycardia is 8 hr . It is devoid of intrinsic activity and, to date, no metabolites with 5-blocking properties have been identified. It was the aim of this study to investigate during a 9-to 18-month period, the anti-anginal effect, tolerance and safety of metoprolol when given orally to a selected group of patients with steady state angina of at least 3 months' duration, and compare the antianginal effects of metoprolol with propranolol in a double-blind cross-over study.
Material and methods
Fourteen patients (twelve male and two female) were selected from out-patients attending the Cardiac Clinic for investigation or review during 1973. The diagnosis of angina pectoris was based on a clinical history of pain, ache or pressure in the chest on physical exertion, relieved by decreasing activity and/or taking nitroglycerin sublingually, together with electrocardiographic evidence of S-T depression during an exercise tolerance test on at least two separate occasions. The patients were aged between 44 and 71 years. Before inclusion in this study, all patients were clinically stabilized on propranolol therapy and were well documented in terms of the response to exercise tolerance, radiological investigation, electrocardiography and laboratory controls. Informed consent was obtained in all cases. A summary of clinical information is presented in Table 1 .
In view of the increasing difficulty in hospital The design of the study is outlined in Fig. 1 . At the commencement of the study there was a run-in period during which previous therapy with propranolol was switched to metoprolol 25 mg at the same daily frequency (q.i.d. in all patients except 5 and 10 who were t.i.d. schedule) for 2 weeks, when a clinical examination and exercise test were performed, and the serum level of metoprolol estimated. For the next 4 weeks, the dose of metoprolol was increased to match the original propranolol therapy on the basis that 40 mg propranolol was equivalent to 50 mg metoprolol relative to the reduction of exercise tachycardia (Johnsson, Nyberg and Solvell, 1975) . Clinical examination, exercise test and serum estimations were again carried out, the latter analysis always being carried out on a post-exercise blood sample.
From the sixth to the fourteenth week, there followed a double-blind cross-over period during which the patient received a 4-week course of metoprolol and propranolol at the same dose levels used during the latter part of the run-in period. Clinical examination and an exercise test were carried out at the end of each period with, once again, post-exercise blood samples being taken for estimation of the plasma level of metoprolol or propranolol, about 10-15 min after the cessation of the exercise test. Drug level estimations were estimated according to the method described by Ervik (1975) .
In the subsequent long term follow-up with metoprolol, all patients continued on a dose of at least 50 mg q.i.d. during the first 4 weeks after which the daily dosage was changed to a morning and evening schedule, with the total daily dose remaining unaltered (always provided there was no deterioration of the anginal stages throughout the study). The exercise test was performed at the same time and usually 2-3 hr after the morning dose of tablets.
Full laboratory control including determination of haemoglobin, white cell count, urinalysis, liver function tests, electrolytes and blood urea, and lipid levels, were carried out at each 4-week visit during the first 14 weeks of the study, and thereafter every 8 weeks.
The exercise test was performed on an electrically braked Elema-Schonander bicycle ergometer using three 3-min step-wise periods, starting in most cases at a load of 50 W, and increasing to 75 W, and possibly 100 W. ECG recordings were made during the last 15 sec of each phase of exercise, and during the post-exercise period from a modified left praecordial lead with the reference electrode to the left leg being sited on the forehead, and the right leg to the right arm, to avoid motion and positional artefacts. The diagnostic criterion of ischaemic electrocardiographic change was the development of at least 1 mm depression of the S-T segment present in five successive beats with a stable isoelectric baseline.
Ratings of leg fatigue, dyspnoea and perceived exertion were assessed on completion of each exercise test based on the following scales: 1, nil; 2, slight; 3, moderate; 4, extreme.
No diaries of the attack or trinitrin (TNT) consumption were kept during the study, as previous attempts to do so were considered unreliable in patients with such relatively infrequent attacks. At each visit, full documentation was recorded on special patient forms provided, including a note of the incidence and severity of unwanted effects (i.e. side effects). An X-ray of the chest was taken before the commencement of the study and again during the fourth month in order to record the cardiac size and shape, and the possible presence of pulmonary congestion. Throughout the study, previous treatment with other drugs, e.g. TNT, valium, diuretic, digitalis, continued unchanged.
Statistical method
Statistical significance was analysed by Wilcoxon's matched pairs signed ranks test for comparison of paired data.
Results
Thirteen of the patients have subjectively remained stable in terms of their attack rate and TNT consumption throughout the period under study (November 1973 to April 1975 Cross-over period (a) Total work. There was a statistically significant increase (P < 0 04) in the total work performed during the metoprolol period in comparison with propranolol (Table 3) .
On looking at the individual responses, one patient showed a better response to propranolol and four patients a better response to metoprolol, based on a 20 % difference in the exercise tolerance results.
(b) ECG reaction. More work was recorded up to the onset of S-T depression with metoprolol than propranolol (P< 0 02). There were two patients who did not have evidence of S-T depression when on metoprolol, which was regarded as of no clinical significance as they both performed comparable degrees of work on the two compounds.
(c) Heart rate and blood pressure recordings. These were the same in the two groups, both at rest and at the end of exercise, indicating equipotency of the dose ratio accepted for the study (Table 3) .
(d) Ratings of leg fatigue, dyspnoea and perceived exertion. These remained the same in the two groups. (e) Plasma levels. Variable levels were noted in the fourteen patients during this cross-over period, with a range of 14-121 ng/g plasma (mean, 61F6) for metoprolol, and a range of 5-159 ng/g plasma (mean 59 8) for propranolol. The therapeutic plasma level for both drugs was of the order of 50-100 ng/g plasma in the method used.
(f) Although the numbers are limited, stratification of the data from the cross-over study suggested that those patients with a previous history of a myocardial infarction had a better exercise tolerance when on either metoprolol or propranolol, in comparison to those patients with no such past history (Table 4) .
Long-term follow-up
Means of the exercise tolerance tests from the eighteenth to the seventy-second week of the study, showed little variation throughout this period, although there was a suggestion of a gradual decrease in the extent of S-T depression recorded at the end of exercise (Table 5 ). There was no significant difference in the exercise tolerance limits as a result of doubling the morning dose when changing from a q.i.d. to a b.d. regime after the eighteenth week (Table 5) . At the seventy-second week, five of ten patients were taking 100 mg b.d.
Means of the plasma levels of metoprolol during this same period showed little varation (Table 6) , in contrast to a dose-response result noted at the second and sixth week of the study.
In regard to the laboratory control, there was no significant change in haemoglobin levels, blood counts or liver function tests. All urine analyses and serum electrolyte levels remained within normal limits throughout the period under study. Side effects were infrequent and only the following were considered of interest. Lassitude in association with excess dreams at night, occurred in a patient when the dose of metoprolol was increased from 150 mg to 200 mg daily, but disappeared when the dose was reduced 10 days later. Bradycardia (heart rate 
Discussion
There are, at present, five known 5-blockers which are said to be cardio-selective, of which practolol (Dunlop and Shanks, 1968) was the first to be developed. While the differing pharmacological profiles of this group are interesting, there are few published reports of comparative clinical studies in angina. Jackson, Atkinson and Oram (1975) have recently compared tolamolol, propranolol, practolol and placebo given during five 1-monthly treatment periods, and concluded that tolamolol was equal in anti-anginal efficiency to propranolol, and superior to practolol. In an acute, oral study, metoprolol, alprenolol (non-selective) and H87/07 (cardio-selective), have all been shown to have a similar effect on exercise-induced angina pectoris (Adolfsson et al., 1974) . In the present study, a definite dose response relationship was seen in those ten patients who received the higher dose of 200 mg daily, the effect of which assumes the order of about a 20 % increase in total work at the eighteenth week in comparison with the second week results when 100 mg daily was given.
In the cross-over study, exercise tolerance was 8 % higher after metoprolol than after propranolol, a finding very similar to that reported by Astrom and Vallin (1974) in a comparison of ICI 66082 and propranolol. Taking a 20% difference in the degree of exercise tolerance, one patient showed a better response to propranolol, and four patients a greater improvement with metoprolol. There was little variation in the systolic blood pressure levels recorded, and post-exercise delta heart rates were similar except in one patient. This confirmed the equipotency of the doses used.
Although stratification of the data suggested a better exercise tolerance by those patients with a previous history of myocardial infarction when on either metoprolol or propranolol, the results were not statistically significant. Similar findings have, however, been previously reported (Hetherington et al., 1973) .
During the long-term follow-up, the degree of exercise tolerance remained unchanged in those patients whose dosage regime was altered from q.i.d. to b.d. (Table 5 ). Subjectively, their anginal state remained stable and unaltered, and it would therefore appear that a dosage regime of metoprolol 100 mg b.d. was acceptable. These findings are in accordance with the pharmacodynamic studies in man .
Since the association between S-T segment depression and the presence of myocardial ischaemia was first discovered (Feil and Segal, 1928) , there have been many conflicting claims and conclusions regarding the results of exercise testing in patients being assessed for the presence of coronary artery disease (Redwood and Epstein, 1972) . The more recent confirmation of the production of lactate (a biochemical index of ischaemia) at the onset of S-T segment depression during exercise by patients with known coronary artery disease (Boudoulas et al., 1974) , should add support to the acceptance of 1 mm of S-T segment depression on exercise testing as evidence of ischaemic heart disease (Hartley, 1975) . Myocardial ischaemia occurs when myocardial oxygen consumption exceeds the capacities of the coronary arteries to deliver oxygen. Propranolol has been shown to reduce S-T segment elevation occurring during coronary occlusion in the dog, suggesting that sympathetic blockade in reducing myocardial contractility may also have reduced oxygen requirements (Braunwald et al., 1969) . Similar findings in man have been observed following intravenous potassium-glucose-insulin treatment in cases of acute myocardial infarction (Sodi-Pallares et al., 1962) , and also in angina patients who were paced before and after aorto-coronary bypass surgery (Chatterjee et al., 1975) . Although still not universally accepted as definite evidence of myocardial ischaemia, S-T segment depression is now being used more frequently in the strict clinical evaluation of patients' progress (Bruce, 1974; Chatterjee et al., 1975) . During the 72 weeks of the present study, there was a steady decrease in the extent of S-T depression at the end of exercise, as well as a gradual increase of up to 20 % in total work performed up to the onset of 1 mm S-T depression, suggesting a gradual improvement in underlying myocardial ischaemia during long term treatment. While the amount of exercise required to elicit S-T segment depression is said to be closely related to the extent of coronary artery obstructive disease (Kattus, 1974) as demonstrated in coronary angiograms, it is difficult to envisage any change occurring in these major branches during several months of treatment. The interpretation of the continuous improvement in S-T changes throughout the study may well be impossible until there is a reasonable method of assessing the development of a collateral circulation in the myocardium.
The increasing number of adverse reports with practolol has focused closer attention on the possibility of adverse reactions to long term treatment with the newer 5-blocking drugs. In this study, there were no cases of oculomucocutaneous syndrome, nor of sclerosing peritonitis. Assessment of antinuclear factor after 15 months' treatment showed no significant abnormality.
Metoprolol has been shown in this 18-month study to be an effective anti-anginal compound with good tolerance and safety. Its effect on exercise tolerance in comparison with propranolol may well be related to its Pi-receptor selectivity.
